SCHEMBL6413657

SCHEMBL6413657

CCN1CNS(=O)(=O)c2cc(OC)ccc21

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRIA2 P42262 16/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5620642 0.92 GRIA2 (0.73) GRIA2
SCHEMBL5351047 0.85 GRIA2 (0.67) GRIA2
SCHEMBL5484687 0.85 GRIA2 (0.58) GRIA2
SCHEMBL5620490 0.84 GRIA2 (0.71) GRIA2
SCHEMBL5621206 0.83 GRIA2 (0.60) GRIA2
SCHEMBL5619678 0.81 GRIA2 (0.73) GRIA2
SCHEMBL5621569 0.81 GRIA2 (0.57) GRIA2
SCHEMBL5185245 0.81 GRIA2 (0.84) GRIA2
SCHEMBL6505317 0.81 GRIA2 (0.72) GRIA2
SCHEMBL5184614 0.80 GRIA2 (0.70) GRIA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065146-A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same LES LABORATOIRES SERVIER (FR) 2005-03-24 US disclosed
EP-1472219-A1 NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2004-11-03 EP disclosed
WO-2003053978-A1 NOVEL BENZOTHIAZINE AND BENZOTHIADIAZINE DERIVATIVES, METHOD FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME LES LABORATOIRES SERVIER (FR) 2003-07-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065146-A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same NR5A2, NR4A3, CBR3 GRIA2 473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.